ABSTRACT
Malondialdehyde, as a biomarker of oxidative stress in pre-eclampsia, is discussed in terms of the determination methods, the validity of the obtained data, and variations in different studies, and it is concluded that there is a need for re-validation of the analytical methods and re-evaluation of its role as a biomarker of oxidative stress.
KEYWORDS:
Declaration of interest
The authors report no conflicts of interest.
Funding
The authors would like to thank Tabriz University of Medical Sciences for partial financial support and declare no conflict of interest.